| Product Code: ETC7746491 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Precision Oncology Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Precision Oncology Market - Industry Life Cycle |
3.4 Japan Precision Oncology Market - Porter's Five Forces |
3.5 Japan Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Japan Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Japan Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Japan |
4.2.2 Technological advancements in precision oncology |
4.2.3 Growing investments in research and development in the oncology sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for precision oncology products |
4.3.2 High costs associated with precision oncology treatments |
4.3.3 Limited access to advanced oncology care in certain regions of Japan |
5 Japan Precision Oncology Market Trends |
6 Japan Precision Oncology Market, By Types |
6.1 Japan Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Japan Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 Japan Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 Japan Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Japan Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Japan Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 Japan Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 Japan Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 Japan Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Japan Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 Japan Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 Japan Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 Japan Precision Oncology Market Import-Export Trade Statistics |
7.1 Japan Precision Oncology Market Export to Major Countries |
7.2 Japan Precision Oncology Market Imports from Major Countries |
8 Japan Precision Oncology Market Key Performance Indicators |
8.1 Adoption rate of precision oncology technologies in Japan |
8.2 Number of clinical trials focusing on precision oncology treatments |
8.3 Rate of integration of precision oncology into standard oncology practice in Japan |
9 Japan Precision Oncology Market - Opportunity Assessment |
9.1 Japan Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Japan Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Japan Precision Oncology Market - Competitive Landscape |
10.1 Japan Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 Japan Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here